history of depression, self-report of CVD, hormone therapy use, and smoking status. [doi.org]

For other postoperative complications (cardiovascular events, stroke, renal failure, respiratory insufficiency, and thromboembolic events), there was no significant difference between the two groups (odds ratio 0.89, 95% CI 0.78-1.01, P   0.06). [ncbi.nlm.nih.gov]

In contrast to the findings in a previous study of high-dose statin therapy, 23 we found no significant between-group difference in the number of subjects with intracranial hemorrhage (six in the rosuvastatin group and nine in the placebo group, P 0.44 [doi.org]

Here, we report two cases of localized rhabdomyolysis associated with mononeuropathy in patients taking statins and suggest possible explanations for this uncommon association. [ncbi.nlm.nih.gov]

Multiple mononeuropathy associated to treatment with pravastatin [in Spanish]. Rev Neurol 2006 Dec 1–15; 43(11): 659–61. PubMed Google Scholar 542. Palmucci L, Doriguzzi C, Orsi L, et al. [doi.org]

Reversible atorvastatin-associated external ophthalmoplegia, anti-acetylcholine receptor antibodies, and ataxia. Arch Ophthalmol 2000 Mar; 118(3): 427–8. PubMed Google Scholar 799. Fraunfelder FW, Richards AB. [doi.org]

Protocol-specified measurements showed no significant differences between the study groups during the follow-up period with respect to the fasting blood glucose level (98 mg per deciliter [5.4 mmol per liter] in both groups, P 0.12) or newly diagnosed glycosuria [doi.org]